PDCD1 and head and neck squamous cell carcinoma: Therefore, our study extended the understanding of the effect of HPV status in the immune microenvironment and furtherly verified these pre-clinical perspectives through the analysis of anti-PD-1 therapy for HNSCC trial patients.